Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS).
Martin-Broto, J., Redondo, A., Valverde, C., Vaz, M.A., Mora, J., Garcia del Muro, X., Gutierrez, A., Tous, C., Carnero, A., Marcilla, D., Carranza, A., Sancho, P., Martinez-Trufero, J., Diaz-BeveridgLangue:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx536
Date:
September, 2017
Fichier:
PDF, 713 KB
english, 2017
File converter
Plus de résultats de recherche
More benefits 
